谷歌浏览器插件
订阅小程序
在清言上使用

Study Design and Rationale for IFCT- 2203 TAXIO: A Study That Aims to Evaluate the Effectiveness of a First-Line Chemotherapy Regimen Without Etoposide, Combined with Durvalumab, for Patients with Extensive Disease Small Cell Lung Cancer.

Respiratory Medicine and Research(2024)

引用 0|浏览14
关键词
Small cell lung cancer,Chemotherapy,Taxane,Immunotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要